 |
| De Montfort's artificial pancreas--Courtesy De Montfort U. |
Two more advances in insulin pump technology this week offer glimpses of what could soon be an actual artificial pancreas, the combination insulin pump and glucose monitor long desired in the diabetes market. Researchers at De Montfort University in the U.K. unveiled an implantable device designed to automatically regulate glucose levels. The scientists, who developed the device over 20 years, are shooting for a 2016 clinical trial for the artificial pancreas. On this side of the Atlantic, Johnson & Johnson's ($JNJ) Animas division won Canadian approval of its closed-loop Vibe system, thought to be a precursor to the artificial pancreas. Here's the U.K. story and the Animas report from FierceMedicalDevices.